¡Ø Ãß¼® ¿¬ÈÞ ÈÞ¹«¾È³» : 2024³â 9¿ù 16ÀÏ(¿ù) ~ 2024³â 9¿ù 18ÀÏ(¼ö)

½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1511889

â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® ¸®Æ÷Æ® : Á¦Ç°º°, Çüź°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2024-2030³â)

Wound Cleanser Products Market Size, Share & Trends Analysis Report By Product (Wetting Agents, Antiseptic), By Form (Sprays, Solutions), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 300 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óÇ°Àº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠ¸®Æ÷Æ®¿¡ µû¸£¸é ¼¼°èÀÇ Ã¢»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 27¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, ¿¹Ãø ±â°£ Áß CAGRÀº 4.69%¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¼ö¼ú ºÎÀ§ °¨¿°(SSI) ¹ß»ý·ü Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡ µî ´Ù¾çÇÑ ¿äÀÎÀÌ ÀÛ¿ëÇÏ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀåÀÇ Å« ¿øµ¿·ÂÀº ¼ö¼ú ºÎÀ§ °¨¿°(SSI) Áõ°¡ÀÔ´Ï´Ù. ¼ö¼ú ȯÀÚ´Â ¼ö¼ú ºÎÀ§ °¨¿°(SSI)ÀÇ À§ÇèÀÌ ³ôÀ¸¸ç, ÀÌ·Î ÀÎÇØ ÀÔ¿ø ±â°£ÀÌ ±æ¾îÁö°í ÀÇ·áºñ°¡ Áõ°¡Çϸç ÇÕº´ÁõÀ» À¯¹ßÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ÀÇ·á Àü¹®°¡µéÀº ¼ö¼ú ºÎÀ§ °¨¿° ¹ß»ý·üÀ» ³·Ãß±â À§ÇØ È¿°úÀûÀÎ »óó ¼¼Ã´ ¼Ö·ç¼Ç »ç¿ë°ú °°Àº ¾ö°ÝÇÑ °¨¿° °ü¸® ÀýÂ÷¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. ¼ö¼ú °á°ú¸¦ °³¼±ÇÏ°í ¼ö¼ú ÈÄ °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇØ Ç×±Õ¼ºÀ» °®Ãá °í±Þ ¼¼Á¤Á¦, Àú¿ë·®ÀÌÁö¸¸ È¿°úÀûÀΠó¹æ¿¡ ´ëÇÑ ÀÇ·á ½Ã¼³ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀåÀÌ È®´ëµÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿¹¸¦ µé¾î Antimicrobial Resistance &Infection ControlÀÇ 2022³â ±â»ç¿¡ µû¸£¸é ¼ö¼ú »óó¿Í °ü·ÃµÈ SSI¸¦ ÃßÁ¤ÇÏ´Â ¿¬±¸¸¦ ¼öÇàÇÑ °á°ú, 338¸íÀÇ È¯ÀÚ Áß 245¸í(72.5%)Àº 3Â÷ º´¿ø¿¡¼­ 93¸í(27.5%)Àº 2Â÷ º´¿ø¿¡¼­ ¼ö¼ú »óó¸¦ Ä¡·áÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù.)ÀÇ È¯ÀÚÀÇ ¼ö¼úâ»ó ½Ã¼úÀ» ½ÃÇàÇÑ °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ±ú²ýÇÏ°Ô ¿À¿°µÈ »óó¿¡ ºñÇØ ¿À¿°µÈ »óó¿¡¼­ SSI À¯º´·üÀÌ ¾à 43.6%·Î ³ô°Ô ³ªÅ¸³µ½À´Ï´Ù. ÀÌó·³ ¿¹Ãø ±â°£ Áß ½ÃÀå È®´ë¸¦ ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î´Â ¿Ü»ó¼º »óó ¹ß»ý·ü Áõ°¡¿Í SSI À¯º´·ü Áõ°¡ µîÀÌ ÀÖ½À´Ï´Ù.

¶ÇÇÑ ¿¹¹æÀÇÇп¡ ´ëÇÑ °ü½ÉÀÌ Ã¢»ó ¼¼Á¤Á¦ Á¦Ç° ¼ö¿ä¸¦ °ßÀÎÇÏ°í ÀÖ½À´Ï´Ù. ƯÈ÷ °íÀ§Çè ¼ö¼ú¿¡¼­ ¼ö¼ú ºÎÀ§ °¨¿°(SSI) ¹ß»ý·üÀ» ³·Ãß±â À§ÇÑ ¿¹¹æ Á¶Ä¡ÀÇ Á߿伺À» ÀνÄÇÏ´Â ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ°¡ Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù. °¨¿° À§ÇèÀ» ÁÙÀ̱â À§ÇØ ¿¹¹æÀû Ä¡·á·Î ÀüȯÇÏ´Â °ÍÀº Ư¼ö ¼¼Á¤Á¦ »ç¿ëÀ» Æ÷ÇÔÇÑ ¾ö°ÝÇÑ »óó °ü¸® ÇÁ·ÎÅäÄÝÀ» »ç¿ëÇÏ´Â °ÍÀ» Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó »óó °ü¸® Á¦Á¶¾÷üµéÀº ÀÇ·á ½Ã¼³ÀÇ º¯È­ÇÏ´Â ¿ä±¸»çÇ׿¡ ¸ÂÃß¾î ¸ÂÃãÇüÀ¸·Î »õ·Ó°í È¿°úÀûÀÎ ¼¼Á¤Á¦¸¦ °³¹ßÇÏ´Â µ¥ ÁÖ·ÂÇÏ°í ÀÖ½À´Ï´Ù. ÀÌ´Â ¼ö¼ú ºÎÀ§ °¨¿° Áõ°¡·Î ÀÎÇÑ »ê¾÷ È®ÀåÀ» À¯ÁöÇÏ°í ÀÖ½À´Ï´Ù.

â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Á¦Ç°º°·Î´Â ºñ¿ë È¿À²ÀûÀÎ ÇコÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ÆÞ½º ¼¼Ã´ ½Ã½ºÅÛ ºÎ¹®ÀÌ ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR 7.82%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º´¿ø ÀçÀÔ¿øÀ» ÁÙ¿©¾ß ÇÒ Çʿ伺ÀÌ »óó °á°ú¿Í Àü¹ÝÀûÀΠȯÀÚ ¸¸Á·µµ Çâ»ó¿¡ ±â¿©ÇÏ´Â ÆÞ½º ¼¼Ã´ ½Ã½ºÅÛÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ°í ÀÖ½À´Ï´Ù.
  • Çüź°·Î´Â ¹°Æ¼½´ ºÎ¹®ÀÌ ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR 5.15%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. »óó ¼¼Ã´ ¹°Æ¼½´ÀÇ ºÎµå·¯¿î Áú°¨°ú Ä¡·á Ư¼ºÀº »óó¸¦ û¼ÒÇÏ´Â µ¿¾È ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½ÃÅ°±â ¶§¹®¿¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀÔ´Ï´Ù.
  • ¿ëµµº°·Î´Â ¸¸¼º »óó ºÐ¾ß°¡ ¿¹Ãø ±â°£ Áß 5.20%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÃÖÁ¾ ¿ëµµº°·Î´Â º´¿ø ºÎ¹®ÀÌ ¿¹Ãø ±â°£ Áß °¡Àå ºü¸¥ CAGR 5.05%¸¦ ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º´¿ø¿¡¼­´Â ÀÏ°üµÈ ¾çÁúÀÇ È¯ÀÚ Ä¡·á¸¦ º¸ÀåÇϱâ À§ÇØ Ç¥ÁØÈ­µÈ »óó °ü¸® ÇÁ·ÎÅäÄÝÀ» äÅÃÇÏ´Â °æ¿ì°¡ ¸¹½À´Ï´Ù. ÀÌ·¯ÇÑ ÇÁ·ÎÅäÄÝ¿¡ Àü¿ë »óó °ü¸® Á¦Ç°À» Æ÷ÇÔ½ÃÅ°¸é ±ÇÀå »çÇ×À» ÁؼöÇÏ°í ÀÇ·áÁøÀÇ ÀÓ»ó °á°ú¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå â»ó ¼¼Á¤Á¦ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • º¸Á¶ ½ÃÀå Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
    • ½ÃÀå ±âȸ ºÐ¼®
    • ½ÃÀåÀÌ ÇØ°áÇØ¾ß ÇÒ °úÁ¦ ºÐ¼®
  • â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå : Á¦Ç° ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå º¯µ¿ ºÐ¼®
  • â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, 2018-2030³â
  • ½ÀÀ±Á¦
  • ¹æºÎÁ¦
  • º¸½ÀÁ¦
  • ÆÞ½º ¼¼Á¤ ½Ã½ºÅÛ
  • ±âŸ

Á¦5Àå â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå : ÇüÅ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå º¯µ¿ ºÐ¼®
  • â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, 2018-2030³â
  • ½ºÇÁ·¹ÀÌ
  • ¼Ö·ç¼Ç
  • ¹°Æ¼½´
  • ±âŸ

Á¦6Àå â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå : ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå º¯µ¿ ºÐ¼®
  • â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, 2018-2030³â
  • ¸¸¼º â»ó
  • ±Þ¼º â»ó

Á¦7Àå â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå : ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤µ¿Ç⠺м®

  • ºÎ¹® ´ë½Ãº¸µå
  • â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå º¯µ¿ ºÐ¼®
  • â»ó ¼¼Á¤Á¦ Á¦Ç° ½ÃÀå ±Ô¸ð¿Í µ¿Ç⠺м®, 2018-2030³â
  • º´¿ø
  • Àü¹® Ŭ¸®´Ð
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ
  • ȨÄɾî
  • ±âŸ

Á¦8Àå â»ó ¼¼Á¤Á¦ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м® Á¦Ç°º°, Çüź°, ¿ëµµº°, ÃÖÁ¾ ¿ëµµº°

  • Áö¿ª ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ½ÃÀå Âü¿© ±â¾÷ÀÇ ºÐ·ù
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Coloplast Corp
    • Smith+Nephew
    • B. Braun SE
    • Johnson &Johnson Services Inc.
    • 3M
    • Medline Industries, Inc.
    • ConvaTec
    • Cardinal Health
    • Integra LifeSciences
    • Molnlycke Healthcare
    • Stryker
    • Zimmer Biomet
    • Heraeus Holding
    • Judd Medical Limited
  • È÷Æ®¸Ê ºÐ¼®/±â¾÷ ½ÃÀå ÇöȲ ºÐ¼®
  • 2023³â ±â¾÷ ½ÃÀå Á¡À¯À² ÃßÁ¤ ºÐ¼®
  • ±âŸ ÁÖ¿ä ½ÃÀå ±â¾÷ ¸®½ºÆ®
KSA 24.07.17

Wound Cleanser Products Market Growth & Trends:

The global wound cleanser products market size is anticipated to reach USD 2.79 billion by 2030, exhibiting a CAGR of 4.69% during the forecast period, according to a new report by Grand View Research, Inc. The market growth is driven by numerous factors such as increasing incidence of surgical site infection (SSIs), rising healthcare expenditure, and increasing geriatric population.

The market growth is significantly driven by the rising number of surgical site infections (SSIs). Patients undergoing surgery are at an increased risk of surgical site infections (SSIs), which can result in prolonged hospital stays, higher healthcare expenses, and even complications. As a result, healthcare professionals focus on strict infection control procedures, such as using effective wound-cleaning solutions to decrease the incidence of surgical site infections. The market for wound cleanser products is expected to develop as a result of the growing demand for advanced cleansers with antimicrobial properties and moderate but effective formulations from healthcare facilities that improve surgical results and reduce the risk of post-operative infections.

For instance, as per the article by Antimicrobial Resistance & Infection Control in 2022, a study was conducted to estimate SSIs associated with surgical wounds. It was found that, of 338 patients, tertiary hospitals performed 245 (72.5%) and secondary hospitals performed 93 (27.5%) surgical wound procedures for patients. Compared to clean-contaminated wounds, the prevalence of SSI was greater in contaminated wounds, approximately 43.6%. Thus, some of the major factors expected to drive market expansion over the forecast period include an increase in the incidence of traumatic wounds and an increase in the prevalence of SSI.

Additionally, the focus on preventive healthcare practices drives the demand for wound cleaner products. Increasing numbers of healthcare providers are discovering the importance of preventive measures in reducing the incidence of surgical site infections (SSIs), especially during high-risk surgical operations. To reduce the risk of infections, this shift towards preventative treatment involves using stringent wound care protocols, which may include the use of specialty cleansers. Due to this, wound care manufacturers focus on developing novel and effective cleanser formulas that are customized to meet the changing requirements of healthcare facilities. This helps maintain the industry's expansion driven by the rising number of surgical site infections.

Wound Cleanser Products Market Report Highlights:

  • Based on product, the pulsed lavage systems segment is expected to register the fastest CAGR of 7.82% during the forecast period owing to the growing emphasis on cost-effective healthcare solutions. The need for reducing hospital readmissions is propelling the adoption of pulsed lavage systems, as they contribute to improved wound outcomes and overall patient satisfaction.
  • Based on form, the wipes segment is expected to register the fastest CAGR of 5.15% during the forecast period. The soft texture and therapeutic properties of wound cleanser wipes increase the comfort level of patients while having their wounds cleaned, thus, driving the segment growth.
  • Based on application, the chronic wounds segment is expected to register the fastest CAGR of 5.20% during the forecast period, owing to the rising geriatric population which is more susceptible to diabetes.
  • Based on end-use, the hospitals segment is expected to register the fastest CAGR of 5.05% during the forecast period. Standardized wound care protocols are often employed in hospitals to ensure consistent high-quality patient care. Including specialized wound cleansing products into these procedures promotes adherence to recommended practices and improves clinical results for healthcare practitioners.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Wound Cleanser Products Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Technological Advancements
      • 3.2.1.2. Increasing Prevalence of Chronic Diseases
      • 3.2.1.3. Increasing Number of Ambulatory Surgical Centers
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Stringent Manufacturing Policies
      • 3.2.2.2. High Cost of Advanced Wound Cleanser Products And Chronic Wound Treatments
    • 3.2.3. Market Opportunities Analysis
      • 3.2.3.1. Increasing Healthcare Expenditure
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Risk of Allergic Reactions To Products Used To Clean Wounds
  • 3.3. Wound Cleanser Products Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Wound Cleanser Products Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Wound Cleanser Products Market Product Movement Analysis
  • 4.3. Wound Cleanser Products Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Wetting Agents
    • 4.4.1. Wetting Agents Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Antiseptic
    • 4.5.1. Antiseptic Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Moisturizers
    • 4.6.1. Moisturizer Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Pulsed Lavage Systems
    • 4.7.1. Pulsed Lavage Systems Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.2. Disposable
      • 4.7.2.1. Disposable Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.3. Reusable
      • 4.7.3.1. Reusable Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.7.4. Semi Disposable
      • 4.7.4.1. Semi Disposable Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Wound Cleanser Products Market: Form Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Wound Cleanser Products Market Form Movement Analysis
  • 5.3. Wound Cleanser Products Market Size & Trend Analysis, by Form, 2018 to 2030 (USD Million)
  • 5.4. Sprays
    • 5.4.1. Sprays Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Solutions
    • 5.5.1. Solutions Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Wipes
    • 5.6.1. Wipes Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Wound Cleanser Products Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Wound Cleanser Products Market Application Movement Analysis
  • 6.3. Wound Cleanser Products Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Chronic Wounds
    • 6.4.1. Chronic Wounds Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Diabetic Foot Ulcers
      • 6.4.2.1. Diabetic Foot Ulcers Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Pressure Ulcers
      • 6.4.3.1. Pressure Ulcers Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Venous Leg Ulcers
      • 6.4.4.1. Venous Leg Ulcers Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Other Chronic Wounds
      • 6.4.5.1. Other Chronic Wounds Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Acute Wounds
    • 6.5.1. Acute Wounds Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Surgical & Traumatic Wounds
      • 6.5.2.1. Surgical & Traumatic Wounds Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Burns
      • 6.5.3.1. Burns Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Wound Cleanser Products Market: End-Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Wound Cleanser Products Market End-Use Movement Analysis
  • 7.3. Wound Cleanser Products Market Size & Trend Analysis, by End-Use, 2018 to 2030 (USD Million)
  • 7.4. Hospitals
    • 7.4.1. Hospitals Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Specialty Clinics
    • 7.5.1. Specialty Clinics Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Ambulatory Surgery Centers
    • 7.6.1. Ambulatory Surgery Centers Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Home Care
    • 7.7.1. Home Care Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8. Others
    • 7.8.1. Others Wound Cleanser Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Wound Cleanser Products Market: Regional Estimates & Trend Analysis By Product, By Form, By Application, By End-Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 8.3. North America
    • 8.3.1. North America Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Competitive Scenario
      • 8.3.2.3. Regulatory Scenario
      • 8.3.2.4. Reimbursement Scenario
      • 8.3.2.5. U.S. Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Competitive Scenario
      • 8.3.3.3. Regulatory Scenario
      • 8.3.3.4. Reimbursement Scenario
      • 8.3.3.5. Canada Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Competitive Scenario
      • 8.4.2.3. Regulatory Scenario
      • 8.4.2.4. Reimbursement Scenario
      • 8.4.2.5. UK Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Competitive Scenario
      • 8.4.3.3. Regulatory Scenario
      • 8.4.3.4. Reimbursement Scenario
      • 8.4.3.5. Germany Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Competitive Scenario
      • 8.4.4.3. Regulatory Scenario
      • 8.4.4.4. Reimbursement Scenario
      • 8.4.4.5. France Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Competitive Scenario
      • 8.4.5.3. Regulatory Scenario
      • 8.4.5.4. Reimbursement Scenario
      • 8.4.5.5. Italy Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Competitive Scenario
      • 8.4.6.3. Regulatory Scenario
      • 8.4.6.4. Reimbursement Scenario
      • 8.4.6.5. Spain Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Denmark
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Competitive Scenario
      • 8.4.7.3. Regulatory Scenario
      • 8.4.7.4. Reimbursement Scenario
      • 8.4.7.5. Denmark Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.8. Sweden
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Competitive Scenario
      • 8.4.8.3. Regulatory Scenario
      • 8.4.8.4. Reimbursement Scenario
      • 8.4.8.5. Sweden Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key Country Dynamics
      • 8.4.9.2. Competitive Scenario
      • 8.4.9.3. Regulatory Scenario
      • 8.4.9.4. Reimbursement Scenario
      • 8.4.9.5. Norway Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Japan
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Scenario
      • 8.5.2.4. Reimbursement Scenario
      • 8.5.2.5. Japan Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. China
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Scenario
      • 8.5.3.4. Reimbursement Scenario
      • 8.5.3.5. China Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Scenario
      • 8.5.4.4. Reimbursement Scenario
      • 8.5.4.5. India Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Competitive Scenario
      • 8.5.5.3. Regulatory Scenario
      • 8.5.5.4. Reimbursement Scenario
      • 8.5.5.5. South Korea Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Competitive Scenario
      • 8.5.6.3. Regulatory Scenario
      • 8.5.6.4. Reimbursement Scenario
      • 8.5.6.5. Australia Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Scenario
      • 8.5.7.4. Reimbursement Scenario
      • 8.5.7.5. Thailand Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Scenario
      • 8.6.2.4. Reimbursement Scenario
      • 8.6.2.5. Brazil Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. Mexico
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Scenario
      • 8.6.3.4. Reimbursement Scenario
      • 8.6.3.5. Mexico Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. Argentina
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Scenario
      • 8.6.4.4. Reimbursement Scenario
      • 8.6.4.5. Argentina Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Middle East & Africa
    • 8.7.1. Middle East & Africa Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Scenario
      • 8.7.2.4. Reimbursement Scenario
      • 8.7.2.5. South Africa Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Scenario
      • 8.7.3.4. Reimbursement Scenario
      • 8.7.3.5. Saudi Arabia Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Competitive Scenario
      • 8.7.4.3. Regulatory Scenario
      • 8.7.4.4. Reimbursement Scenario
      • 8.7.4.5. UAE Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key Country Dynamics
      • 8.7.5.2. Competitive Scenario
      • 8.7.5.3. Regulatory Scenario
      • 8.7.5.4. Reimbursement Scenario
    • 8.7.6. Kuwait Wound Cleanser Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Coloplast Corp
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Service Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Smith + Nephew
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Service Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. B. Braun SE
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Service Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Johnson & Johnson Services Inc.
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Service Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. 3M
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Service Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Medline Industries, Inc.
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Service Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. ConvaTec
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Service Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Cardinal Health
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Service Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. Integra LifeSciences
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Service Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Molnlycke Healthcare
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Service Benchmarking
      • 9.2.10.4. Strategic Initiatives
    • 9.2.11. Stryker
      • 9.2.11.1. Company Overview
      • 9.2.11.2. Financial Performance
      • 9.2.11.3. Service Benchmarking
      • 9.2.11.4. Strategic Initiatives
    • 9.2.12. Zimmer Biomet
      • 9.2.12.1. Company Overview
      • 9.2.12.2. Financial Performance
      • 9.2.12.3. Service Benchmarking
      • 9.2.12.4. Strategic Initiatives
    • 9.2.13. Heraeus Holding
      • 9.2.13.1. Company Overview
      • 9.2.13.2. Financial Performance
      • 9.2.13.3. Service Benchmarking
      • 9.2.13.4. Strategic Initiatives
    • 9.2.14. Judd Medical Limited
      • 9.2.14.1. Company Overview
      • 9.2.14.2. Financial Performance
      • 9.2.14.3. Service Benchmarking
      • 9.2.14.4. Strategic Initiatives
  • 9.3. Heat Map Analysis/ Company Market Position Analysis
  • 9.4. Estimated Company Market Share Analysis, 2023
  • 9.5. List of Other Key Market Players
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦